Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-Associated Cancers
NCT05639972Phase 2Recruiting
- Sponsor
- Christian Hinrichs
- Start
- Aug 2025
- Primary completion
- Oct 2028
- Modality
- Gene Editing, Gene Silencing, TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of KITE-439 in HPV-associated cancer, sponsored by Christian Hinrichs. Started Aug 2025; status: recruiting.
02
Drugs
KITE-439
03
Conditions
HPV-associated cancer
Beyond the preview
Go deeper on NCT05639972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05639972.